Skip to content
Our reporters bring you news and highlights from BIO’s in-person and virtual events.
Microbial ecology and its potential applications are gaining prominence in biotechnology and healthcare. Cambridge-based Concerto Biosciences is helping drive advances in this area with […]
NIH Innovation Zone 2024: Concerto Biosciences illuminates collaboration of microbes Read More »
Immuto Scientific is opening new frontiers in the fight against cancer by developing precision biotherapeutics that target highly cancer-specific surface protein conformations. Their ultimate
NIH Innovation Zone 2024: Immuto Scientific identifies new cancer targets Read More »
Talus Bio’s collaborative and innovative approach to unlocking the therapeutic potential of targeting transcription factors for cancer and other diseases is putting them at
Injecting medicine can be a scary prospect. It is not just the fear of needles that can prevent patients from self-administration. Even traditional auto-injector
NIH Innovation Zone 2024: Pirouette Medical is innovating safer, easier auto-injections Read More »
Artificial intelligence (AI) is on everyone’s mind these days. In healthcare and biotech, AI is addressing some of the industry’s biggest challenges, as well
NIH Innovation Zone 2024: Modality.AI tackles remote neurological assessment Read More »
From oncology to AI to burgeoning biotech hubs worldwide, the 2024 BIO International Convention brought together the global biotech community to discuss key trends
BIO 2024: 5 takeaways about the biotech business ecosystem Read More »
The COVID pandemic underscored the reality of medical inequity worldwide, a longstanding issue reflected in clinical trials, particularly regarding the absence of race and
BIO 2024: Can data improve clinical trial diversity? Read More »
In 2024, the BIO International Convention is shining a bright light on patients—in line with one of the Biotechnology Innovation Organization’s strategic priorities to
BIO 2024: What patient advocates said about AFPs, Medicare Part D, and more Read More »
With rapid innovations in agriculture, energy, and environmental biotech, the industry must try to educate regulators and the public about the latest scientific advances
BIO 2024: Education can improve regulation, biotech innovators say Read More »
Investing in women’s health is a gold mine that few healthcare investors have yet to tap, according to a new study that has come
BIO 2024: Investing in women’s health is an untapped gold mine Read More »
